veratridine has been researched along with phosphoramidon in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
Marvizón, JC; Song, B | 1 |
2 other study(ies) available for veratridine and phosphoramidon
Article | Year |
---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.
Topics: Aminopeptidases; Animals; Anti-Bacterial Agents; Captopril; Endopeptidases; Enzyme Inhibitors; Glycopeptides; In Vitro Techniques; Lumbosacral Region; Narcotic Antagonists; Neprilysin; Opioid Peptides; Peptide Fragments; Peptide Hydrolases; Peptides; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Somatostatin; Veratridine | 2003 |